Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NAGE Niagen Bioscience

Post-Mkt 03-25 19:05:09 EDT

4.52

-0.02

-0.44%

盘后4.54

+0.02+0.44%

18:36 EDT

High4.65	Low4.50	Vol674.06K
Open4.58	D1 Closing4.54	Amplitude3.30%
Mkt Cap361.24M	Tradable Cap232.39M	Total Shares79.92M
T/O3.08M	T/O Rate1.31%	Tradable Shares51.41M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":4.52,"timestamp":1774468800000,"preClose":4.54,"halted":0,"volume":674055,"hourTrading":{"tag":"盘后","latestPrice":4.54,"preClose":4.52,"latestTime":"18:36 EDT","volume":27779,"amount":125583.6782165,"timestamp":1774478186161,"change":0.02,"changeRate":0.004425,"amplitude":0.008894},"delay":0,"changeRate":-0.004405286343612437,"floatShares":51414700,"shares":79919957,"eps":0.2,"marketStatus":"Post-Mkt","change":-0.02,"latestTime":"03-25 19:05:09 EDT","open":4.58,"high":4.65,"low":4.5001,"amount":3078870.912675,"amplitude":0.033018,"askPrice":4.54,"askSize":98,"bidPrice":4.5,"bidSize":50,"shortable":3,"etf":0,"ttmEps":0.2,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774483200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":4.54,"preHourTrading":{"tag":"盘前","latestPrice":4.7,"preClose":4.54,"latestTime":"09:24 EDT","volume":49,"amount":228.1799905,"timestamp":1774445053461,"change":0.16,"changeRate":0.035242,"amplitude":0.039648},"postHourTrading":{"tag":"盘后","latestPrice":4.54,"preClose":4.52,"latestTime":"18:36 EDT","volume":27779,"amount":125583.6782165,"timestamp":1774478186161,"change":0.02,"changeRate":0.004425,"amplitude":0.008894},"volumeRatio":0.619615,"impliedVol":1.5714,"impliedVolPercentile":0.8884},"requestUrl":"/m/hq/s/NAGE/tweets","defaultTab":"tweets","newsList":[{"id":"2620236672","title":"Niagen Bioscience Doubles Share Repurchase Authorization to $20M","url":"https://stock-news.laohu8.com/highlight/detail?id=2620236672","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620236672?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:59","pubTimestamp":1773925173,"startTime":"0","endTime":"0","summary":"Niagen Bioscience ( ($NAGE) ) has shared an update. On March 19, 2026, Los Angeles-based Niagen Bioscience, a specialist in NAD+ science and health...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-doubles-share-repurchase-authorization-to-20m?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-doubles-share-repurchase-authorization-to-20m?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE","BK4183","BK4121"],"gpt_icon":0},{"id":"2620931223","title":"Niagen Bioscience increases share repurchase program to $20M","url":"https://stock-news.laohu8.com/highlight/detail?id=2620931223","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620931223?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:50","pubTimestamp":1773924632,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) announced that its board of directors has authorized an increase to the company’s previously disclosed share repurchase pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-increases-share-repurchase-program-to-20m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-increases-share-repurchase-program-to-20m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE","BK4183","BK4121"],"gpt_icon":0},{"id":"2620228824","title":"Niagen Bioscience Increases Share Repurchase Program to $20 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228824","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228824?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:32","pubTimestamp":1773923520,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nTUA1WD0GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAGE","BK4183","BK4121"],"gpt_icon":0},{"id":"2620925565","title":"Niagen Bioscience to present at the 38th Annual ROTH Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620925565","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620925565?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:32","pubTimestamp":1773837148,"startTime":"0","endTime":"0","summary":"Niagen Bioscience to present at the 38th Annual ROTH Conference               Niagen Bioscience will participate in the 38th Annual ROTH Conference in Dana Point, California, from March 22 to 24, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL2zQFSn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE"],"gpt_icon":0},{"id":"2620422335","title":"Niagen Bioscience tops 300 external research agreements for Niagen and cites 45 published clinical studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2620422335","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620422335?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:33","pubTimestamp":1773750839,"startTime":"0","endTime":"0","summary":"Niagen Bioscience said its external research program surpassed 300 material transfer agreements and has contributed to 45 published clinical studies.The company reported the program includes agreements with more than 200 institutions across 34 countries and has contributed to more than 225 peer-reviewed publications.Niagen Bioscience estimated the program has generated more than USD 200 million in third-party research value or funding and has resulted in a patent portfolio of over 50 granted patents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL2LhNfC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"gpt_icon":0},{"id":"2620228534","title":"Niagen Bioscience Surpasses 300 External Research Agreements From Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228534","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228534?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:32","pubTimestamp":1773750720,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUA340FYW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","NAGE","BK4183"],"gpt_icon":0},{"id":"2618541958","title":"Niagen Bioscience launches Niagen Skincare Innovation Lab and debuts Niagen NanoCloud topical product","url":"https://stock-news.laohu8.com/highlight/detail?id=2618541958","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618541958?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:32","pubTimestamp":1773145937,"startTime":"0","endTime":"0","summary":"Niagen Bioscience launched the Niagen Skincare Innovation Lab to expand into skincare through a limited-release model. The company debuted Niagen NanoCloud, a dermatologist-tested topical product using a sealed, waterless sachet format designed to reduce ingredient degradation. Niagen NanoCloud is available on truniagen.com for USD 59 and includes 30 sachets.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL9knwDz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"gpt_icon":0},{"id":"2617573047","title":"Niagen Bioscience Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2617573047","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617573047?lang=en_us&edition=fundamental","pubTime":"2026-03-06 04:38","pubTimestamp":1772743080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2026 15:38 ET (20:38 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"gpt_icon":0},{"id":"2617520873","title":"Niagen Bioscience Inc. Releases Transcript of Fourth Quarter 2025 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520873","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617520873?lang=en_us&edition=fundamental","pubTime":"2026-03-06 02:15","pubTimestamp":1772734521,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL69bGC3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","LTSAP","NAGE","BK4127","BK4121"],"gpt_icon":0},{"id":"2617544145","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2617544145","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617544145?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:27","pubTimestamp":1772713623,"startTime":"0","endTime":"0","summary":"Palladyne AI  shares were over 19% higher pre-bell Thursday after the company reported higher Q4 revenue and narrower non-GAAP net loss.Niagen Bioscience  shares were over 15% higher after the company reported late Wednesday higher Q4 net sales.Stem  stock was up 15%, a day after the company reported a narrower Q4 loss.Broadcom  stock was up 6% after the company reported late Wednesday higher fiscal Q1 adjusted earnings and revenue.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1366192091.USD","LU2430703251.USD","IE00BQXX3C00.GBP","LU1814569148.SGD","BK4141","LU0345769128.USD","LU2461242641.AUD","LU0011850046.USD","LU2860962120.EUR","LU1934455194.USD","LU2462157665.USD","AVGG","LU2213496289.HKD","SGXZ99366536.SGD","LU2041044095.USD","LU0784384876.USD","LU2322448957.HKD","IE00B5949003.HKD","LU0057025933.USD","LU1935042215.USD","LU2211814178.USD","LU1366333091.USD","LU2471134523.USD","IE00B19Z9P08.USD","LU2237443465.HKD","LU1720051017.SGD","LU0354030511.USD","LU0080751232.USD","LU2463028550.USD","IE00B3PB1722.GBP","LU0225283273.USD","LU0215105999.USD","BK4566","LU0511384066.AUD","BK4603","LU0784385170.HKD","IE00BMPRXN33.USD","LU0096362180.USD","LU1153585028.USD","LU1242518931.SGD","LU1629891620.HKD","IE00BVYPNP33.GBP","IE00BJTD4N35.SGD","IE00BK4W5M84.HKD","IE00BJLML261.HKD","LU1935043536.SGD","LU0320765646.SGD","LU2543165471.USD","LU2403377893.USD","LU0345770993.USD","LU0127658192.USD","LU2065170008.USD","IE00BGHQF631.EUR","LU0170899867.USD","LU0949170772.SGD","LU2764263039.SGD","LU2237957811.SGD","LU2471134879.HKD","LU1935042991.SGD","LU1868836914.USD","IE00BN8TJ469.HKD","IE0034235188.USD","LU0545039389.USD","LU0348723411.USD","LU2750360641.GBP","LU2357305700.SGD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0472753341.HKD","LU1934455863.HKD","LU1670628061.USD","LU2083900584.USD","LU1974910355.USD","LU2087625088.SGD","LU0964807845.USD","LU2286300806.USD","LU2065171311.SGD","LU2237443895.HKD","LU0238689110.USD","LU2065171402.SGD","SGXZ23171101.USD","LU0738911758.USD","LU2896262040.SGD","LU0965508806.USD","LU1720051108.HKD","LU0256863902.USD","AVL","BK4554","LU0234570918.USD","LU0316494557.USD","LU2237443622.USD","LU0640476718.USD","LU1169589451.USD","LU0957791311.USD","LU2264538146.SGD","LU2272731865.HKD","LU1914381329.SGD","IE00BK4W5L77.USD","BK4598","LU2250418816.HKD","LU0661504455.SGD","AVS","LU0006306889.USD","IE00BQXX3D17.EUR","LU1127390331.HKD","SG9999003800.SGD","LU2756315664.SGD","LU1988902786.USD","IE00B3S45H60.SGD","LU1815333072.USD","LU2473716301.USD","LU0289961442.SGD","BK4161","LU0868494708.USD","LU1935043023.USD","LU0345769631.USD","LU0109391861.USD","LU2417539215.USD","LU0726765562.USD","IE00B1XK9C88.USD","IE00BJTD4V19.USD","LU0345770308.USD","LU1803068979.SGD","LU2505996509.AUD","LU0444971666.USD","LU2456880835.USD","LU2237438978.USD","LU0124676726.USD","LU0672654240.SGD","IE00BGHQDM52.EUR","LU0079474960.USD","LU0965509101.SGD","LU1778281490.HKD","LU2720916845.USD","LU0198837287.USD","LU2272731600.USD","LU2355687059.USD","LU0942090050.USD","AVGX","LU2106854487.HKD","LU2756315318.SGD","LU2750360997.AUD","LU0784385840.USD","LU2361044865.SGD","LU0353189680.USD","LU1642822529.SGD","LU0889565833.HKD","LU0203347892.USD","IE00B4JS1V06.HKD","LU1917777945.USD","LU2023250504.SGD","LU1548497426.USD","LU0289739343.SGD","LU2430703178.SGD","LU0820561818.USD","IE00BBT3K403.USD","LU2298321311.HKD","LU0053666078.USD","IE00B775H168.HKD","LU1992135472.HKD","LU0985320562.USD","LU0256863811.USD","IE0034235303.USD","BK4183","IE00BZ9MQY76.HKD","LU2471134796.USD","SG9999004303.SGD","LU2360108059.USD","LU0157215616.USD","LU1280957306.USD","LU2471134952.CNY","LU2360106780.USD","LU1989764748.USD","LU1989764664.SGD","BK4543","IE00BJJMRX11.SGD","LU0861579265.USD","LU1244550221.USD","AVGW","LU1732799900.SGD","LU1242518857.USD","LU0203201768.USD","LU2244417387.USD","BK4585","LU0203345920.USD","LU2168564495.EUR","LU2602419157.SGD","LU1316542783.SGD","SGXZ51526630.SGD","LU0069063385.USD","IE0004445015.USD","IE00B42XCP33.USD","LU0187121727.USD","LU1169590202.USD","LU2133065610.SGD","LU1670711123.USD","IE0004445239.USD","LU0943347566.SGD","IE00B894F039.SGD","LU1069344957.HKD","LU0234572021.USD","LU0949170426.SGD","LU0689472784.USD","LU1670711040.USD","BK4096","LU2065169927.USD","STEM","LU2237443978.SGD","LU2361045086.USD","LU0965509283.SGD","LU0417517546.SGD","LU0957808578.USD","LU2237957902.USD","LU2125154935.USD","LU1145028129.USD","LU1934455277.USD","LU2023250843.SGD","LU2430703095.HKD","LU2746668974.SGD","LU2247934214.USD","IE00BWXC8680.SGD","LU0154236417.USD","IE00BQXX3F31.USD","LU1064131342.USD","SG9999015952.SGD","LU2361044949.HKD","SG9999002224.SGD","LU2265009873.SGD","IE00BKPKM429.USD","LU1035775433.USD","LU2236285917.USD","LU0786609619.USD","IE00BDGV0183.EUR","LU1003077747.HKD","LU0203202063.USD","LU0210528500.USD","LU2168564065.EUR","LU1815336760.USD","IE00BYV24P56.USD","LU2347655156.SGD","BK4575","LU1037948541.HKD","LU2279689827.SGD","LU0979878070.USD","LU1804176565.USD","LU0795875169.SGD","IE00BFSS8Q28.SGD","IE00BKDWB100.SGD","LU0106261372.USD","LU1674673428.USD","LU1301847155.USD","LU2746668461.USD","LU2764262908.HKD","LU1551013425.SGD","LU0820562030.AUD","LU0795875086.SGD","LU0912757837.SGD","SG9999011175.SGD","LU0708995401.HKD","IE00BZ1G4Q59.USD","LU2023250330.USD","LU0683600562.USD","LU0823434740.USD","IE00BMPRXR70.SGD","LU0965509010.AUD","IE00BMPRXQ63.HKD","BK4588","BK4533","LU0109392836.USD","LU0345768740.USD","LU2237443549.SGD","LU2125154778.USD","LU0354030438.USD","LU1323610961.USD","LU2211815571.USD","LU1868836757.USD","LU2242649171.HKD","IE00BVYPNQ40.USD","LU0081259029.USD","IE0005OL40V9.USD","LU2487616109.SGD","LU0345768153.USD","LU1992135399.USD","BK4535","LU1232071149.USD","LU1670627923.USD","LU1244550494.USD","LU0274383776.USD","IE00B775SV38.USD","LU1267930730.SGD","LU0823434583.USD","IE00BLSP4239.USD","IE00BFSS7M15.SGD","BK4604","LU0097036916.USD","PDYN","LU0210533765.USD","LU1712237335.SGD","LU0466842654.USD","IE0009356076.USD","LU0476273544.USD","LU1935042488.USD","LU0784383803.USD","LU1244550577.SGD","LU2360032135.SGD","LU0642271901.SGD","LU0719512351.SGD","NAGE","LU0353189763.USD","IE00BVYPNW00.USD","LU1852331112.SGD","LU1037948897.HKD","LU0320765059.SGD","LU0056508442.USD","LU2347655073.USD","LU2505996681.GBP","SG9999015978.USD","LU2272731782.SGD","LU2931357623.SGD","SG9999015945.SGD","LU0820561909.HKD","LU1674673691.USD","BK4515","LU0061475181.USD","LU2168564149.EUR","LU2063271972.USD","LU1670710661.SGD","LU1670710588.SGD","LU0689626769.HKD","LU0210536198.USD","LU2764263203.CNY","LU2089985449.USD","LU0048584097.USD","LU0061474960.USD","SG9999001424.SGD","BK4605","LU1623119135.USD","LU2458330243.SGD","LU2092937221.SGD","LU1868837136.USD","AVGU","LU1691799644.USD","LU2168564222.USD","LU2168563687.JPY","SGXZ81514606.USD","LU2458330169.SGD","BK4551","LU1162221912.USD","LU1868836591.USD","LU0553294199.USD","LU1868837300.USD","SG9999001440.SGD","LU2242650005.HKD","LU2054465674.USD","BK4612","IE00BVYPNV92.GBP","LU0444973449.USD","LU2592432038.USD","LU0251132253.USD","IE00BJJMRY28.SGD","IE00BLSP4452.SGD","LU2420271590.USD","IE00BKVL7J92.USD","LU0868494617.USD","LU0096364046.USD","SG9999015986.USD","LU2322448791.USD","LU2108987350.USD","IE00B1BXHZ80.USD","IE00BN29S564.USD","BK4121","BK4512","SG9999002232.USD","IE00BMCWC346.EUR","IE00B19Z9Z06.USD","LU2237443382.USD","LU0323591593.USD","LU0787776722.HKD","LU0082616367.USD","BK4581","LU1732800096.USD","LU1551013342.USD"],"gpt_icon":1},{"id":"2617549959","title":"Niagen Bioscience price target lowered to $13 from $14 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2617549959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617549959?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:40","pubTimestamp":1772710840,"startTime":"0","endTime":"0","summary":"Canaccord analyst Susan Anderson lowered the firm’s price target on Niagen Bioscience (NAGE) to $13 from $14 and keeps a Buy rating on the shares. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-price-target-lowered-to-13-from-14-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-price-target-lowered-to-13-from-14-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE"],"gpt_icon":0},{"id":"2617651219","title":"Niagen Bioscience Rallies 18% After Hours: Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2617651219","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617651219?lang=en_us&edition=fundamental","pubTime":"2026-03-05 16:56","pubTimestamp":1772700984,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc. surged in after-hours trading after reporting record 2025 results, while maintaining a cautious outlook for 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/03/51059246/niagen-bioscience-rallies-18-after-hours-heres-why","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","BK4150","RSI","NAGE"],"gpt_icon":0},{"id":"2617629245","title":"Niagen Bioscience Inc. Publishes Investor Presentation on NAD+ and Healthy Aging Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2617629245","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617629245?lang=en_us&edition=fundamental","pubTime":"2026-03-05 06:29","pubTimestamp":1772663384,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc. released an investor presentation outlining its NAD+ product portfolio, including the Tru Niagen supplement and the Niagen Plus lineup for IV and injectable formats. The company reported FY 2025 revenue of $129.4 million, net income of $17.4 million, and cash of $64.8 million with no debt. The presentation also highlighted Niagen IV and injectables initiatives, including an NAD+ test kit and a targeted at-home injectable product launch in the first half of 2026, and noted early adoption metrics since the August 2024 launch. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news bri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL1bj7jx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"gpt_icon":0},{"id":"2617649875","title":"Niagen Bioscience sees FY26 revenue up 10%-15%, implying $142.3M-$148.8M","url":"https://stock-news.laohu8.com/highlight/detail?id=2617649875","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617649875?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:45","pubTimestamp":1772660741,"startTime":"0","endTime":"0","summary":"Consensus $152.9M. Sees FY26 gross margin with “slight improvement year-over-year, driven by improvements in inventory cost and product mix.” Publi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-sees-fy26-revenue-up-10-15-implying-142-3m-148-8m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-sees-fy26-revenue-up-10-15-implying-142-3m-148-8m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE"],"gpt_icon":0},{"id":"2617646085","title":"Niagen Bioscience up 39% at $6.88 after Q4 results and guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2617646085","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617646085?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:45","pubTimestamp":1772660721,"startTime":"0","endTime":"0","summary":"16:41 EST Niagen Bioscience (NAGE) up 39% at $6.88 after Q4 results and guidance Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-up-39-at-6-88-after-q4-results-and-guidance-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-up-39-at-6-88-after-q4-results-and-guidance-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","NAGE","BK4121"],"gpt_icon":0},{"id":"2617569526","title":"Niagen Bioscience Q4 net sales rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2617569526","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617569526?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:12","pubTimestamp":1772658744,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Q4 net sales riseOverviewBioscience company's Q4 net sales rose 16%, beating analyst expectationsNet income for Q4 declined due to higher operating expensesGross margin improved 160 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nL1N3ZS1B7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154245756.USD","BK4149","LU0203347892.USD","LU0203345920.USD","BK4567","BK4183","BK4588","BK4585","LU0154245673.USD","BK4121","BK4533","NAGE","CMI"],"gpt_icon":0},{"id":"2617566094","title":"Niagen Bioscience Doubles Annual Profit, CEO Signals Acquisition Hunt And GLP-1-Style Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2617566094","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617566094?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:06","pubTimestamp":1772658381,"startTime":"0","endTime":"0","summary":"NAD+ company Niagen Bioscience doubles profits in 2025, eyes acquisitions and new markets as the longevity market picks up momentum.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/03/51050507/niagen-bioscience-doubles-annual-profit-ceo-signals-acquisition-hunt-and-glp-1-style-expansion","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4121","GLP","BK4183","NAGE","BK4144"],"gpt_icon":0},{"id":"2617667425","title":"Niagen Bioscience Q4 EPS $0.05 Beats $0.02 Estimate, Sales $33.839M Beat $31.705M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2617667425","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617667425?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:03","pubTimestamp":1772658193,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NASDAQ:NAGE) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 127.27 percent. This is a 44.44 percent decrease over earnings of $0.09 per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51050229/niagen-bioscience-q4-eps-0-05-beats-0-02-estimate-sales-33-839m-beat-31-705m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Niagen Bioscience Q4 EPS $0.05 Beats $0.02 Estimate, Sales $33.839M Beat $31.705M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"gpt_icon":0},{"id":"2617456644","title":"Niagen Bioscience posts FY 2025 net income up 2.0x to USD 17.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617456644","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617456644?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:03","pubTimestamp":1772658183,"startTime":"0","endTime":"0","summary":"Niagen Bioscience posts FY 2025 net income up 2.0x to USD 17.4 million               Niagen Bio reported FY 2025 net sales of USD 129.4 million (+30.0% YoY) and net income of USD 17.4 million (2.0x Yo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL4hvxy9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"gpt_icon":0},{"id":"2617566458","title":"BRIEF-Niagen Bioscience Inc Q4 Sales USD 33.839 Million Vs. IBES Estimate USD 31.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617566458","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617566458?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:02","pubTimestamp":1772658166,"startTime":"0","endTime":"0","summary":"BRIEF-Niagen Bioscience Inc Q4 Sales USD 33.839 Million Vs. IBES Estimate USD 31.7 Million\n\n\nMar 04 (Reuters) - Niagen Bioscience Inc Q4 net income USD 4.132 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nPLXE0E1D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121","BK4183"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.niagenplus.com","stockEarnings":[{"period":"1week","weight":-0.0482},{"period":"1month","weight":-0.0658},{"period":"3month","weight":-0.3132},{"period":"6month","weight":-0.5175},{"period":"1year","weight":-0.4026},{"period":"ytd","weight":-0.2862}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":" ","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.045249},{"month":2,"riseRate":0.5,"avgChangeRate":0.181088},{"month":3,"riseRate":0.3,"avgChangeRate":0.052333},{"month":4,"riseRate":0.555556,"avgChangeRate":0.036039},{"month":5,"riseRate":0.5,"avgChangeRate":0.021036},{"month":6,"riseRate":0.6,"avgChangeRate":0.068253},{"month":7,"riseRate":0.5,"avgChangeRate":-0.007412},{"month":8,"riseRate":0.3,"avgChangeRate":-0.041379},{"month":9,"riseRate":0.3,"avgChangeRate":-0.054309},{"month":10,"riseRate":0.2,"avgChangeRate":-0.056092},{"month":11,"riseRate":0.7,"avgChangeRate":0.200397},{"month":12,"riseRate":0.3,"avgChangeRate":-0.024057}],"exchange":"NASDAQ","name":"Niagen Bioscience","nameEN":"Niagen Bioscience"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Niagen Bioscience(NAGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Niagen Bioscience,NAGE,Niagen Bioscience股票,Niagen Bioscience股票老虎,Niagen Bioscience股票老虎国际,Niagen Bioscience行情,Niagen Bioscience股票行情,Niagen Bioscience股价,Niagen Bioscience股市,Niagen Bioscience股票价格,Niagen Bioscience股票交易,Niagen Bioscience股票购买,Niagen Bioscience股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Niagen Bioscience(NAGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}